ArticleBreast cancer research and treatment2022

MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975.

Minhong Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.